Hepatocellular Carcinoma (HCC) Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Hepatocellular Carcinoma (HCC)?
Hepatocellular carcinoma is the most common type of liver cancer. It is an aggressive (fast-growing) cancer that most commonly affects persons with severe liver disease, such as cirrhosis. People with HCC are increasingly being diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD), which can develop to cirrhosis.
What is the Importance of Timely Treatment?
Early treatment of Hepatocellular Carcinoma (HCC) is essential for improving patient outcomes and survival rates. Early discovery enables more effective treatment choices, such as surgical resection, liver transplantation, or local therapy (e.g., ablation or embolisation), which may cure the cancer or considerably postpone its progression. Delaying treatment can cause tumour growth, spread (metastasis), and poor liver function, making cancer more difficult to cure and decreasing the likelihood of a favourable outcome. Early intervention also enhances quality of life by enabling more effective symptom management.
What are the Common Symptoms of Hepatocellular Carcinoma (HCC)?
Tumours may not present symptoms in their early stages. However, as HCC proceeds, you may notice:
- Fullness or a knot under your right ribs (symptoms of an enlarged liver).
- Fullness under your ribs on the left side (symptoms of an expanded spleen).
- Yellowing of the eyes and skin (an indication of jaundice).
- A distended stomach, as if it is overflowing with fluid.
- Appetite loss or feeling full after eating a little meal.
- Unexplained weight loss.
- Nausea and vomiting.
- Itching.
Causes and Risk Factors of Hepatocellular Carcinoma (HCC)
Causes
- Hepatocellular carcinoma occurs when liver cells' DNA undergoes modifications (mutations).
- A cell's DNA contains the instructions for every chemical process in your body. DNA mutations alter these instructions.
- As a result, cells may grow out of control, eventually becoming a tumour—a mass of malignant cells.
Risk Factors
The following conditions enhance your risk of developing HCC:
- Hepatitis B infection: Hepatitis B infection can cause HCC even in the absence of liver cirrhosis or before it develops.
- Hepatitis C Infection: A viral infection that spreads through blood.
- Metabolic dysfunction-associated steatotic liver disease (MASLD): It is a disorder that causes excessive fat to accumulate in the liver.
- Alcohol use disorder: The liver has a tough time processing alcohol. Drinking too much of it can cause cirrhosis and liver cancer.
Connect with our advisor for a PRIORITY response
Latest Research and Technologies in the Treatment of Hepatocellular Carcinoma (HCC) in India
- Recent advances in Hepatocellular Carcinoma (HCC) treatment in India include targeted therapies and immunotherapy. Furthermore, radiofrequency ablation (RFA), transarterial chemoembolisation (TACE), and liver transplantation are becoming more common, with ongoing clinical trials investigating gene therapy and combination medicines to improve treatment outcomes.
Hepatocellular Carcinoma (HCC) Prevention Tips
There are various ways to lower your chance of having HCC. You can do:
- Lower your risk of cirrhosis.
- To lower your risk of developing cirrhosis, avoid drinking alcohol.
- Maintain a healthy weight.
- Vaccinate against hepatitis B.
- You can lower your risk of contracting hepatitis B by getting the vaccine.
- Take steps to prevent hepatitis C.
- Do not use intravenous drugs,
- When getting a piercing or tattoo, look for safe and clean shops.
- Seek treatment for hepatitis B or C infections.
Treatment options for Hepatocellular Carcinoma (HCC)
Treatments include:
Surgery: The surgical treatments for HCC are hepatectomy (removal of the diseased section of the liver) or liver transplantation.
Cost Start From USD 25000 - USD 35000Explore Options
Ablation therapy: This involves the use of a specialised needle to burn malignancies. The needle can direct highly hot energy (microwaves or radiofrequency waves) or extremely cold.
Embolisation: It is the process of implanting a material directly into the arteries that supply the tumour, blocking blood flow.
Radiation therapy: Providers may recommend radiation therapy to treat tiny cancers that cannot be removed surgically or destroyed through ablation.
Immunotherapy: Immunotherapy drugs are also used to treat advanced HCC. They help your immune system recognise and combat cancer cells.
Cost Start From USD 3000 - USD 5000Explore Options
Targeted therapy: These medications treat advanced HCC. This medication inhibits the signal that tells cancer cells to continue growing.
Cost Start From USD 8000 - USD 12000Explore Options
The following tests can assist in confirming a diagnosis:
- Blood tests: Your provider may check your blood for indicators of HCC, such as elevated alpha-fetoprotein (AFP) levels. Elevated AFP levels may indicate HCC or a disease that can develop into HCC, such as hepatitis infection or liver cirrhosis.
- Imaging scans: Imaging treatments such as an ultrasound, computed tomography (CT) scan, magnetic resonance imaging (MRI), or angiography can detect cancers (or indicators of a tumour) within your liver.
- Liver biopsy: Your doctor may do a liver biopsy to look for cancer cells. If your bloodwork and imaging scans do not provide enough information to make a diagnosis, you may need this test.
Rehabilitation treatments for Hepatocellular Carcinoma (HCC) are aimed at increasing quality of life, accelerating physical recovery, and minimising therapeutic side effects. Here are the main rehabilitation alternatives for HCC patients:
Physical Rehabilitation: After liver surgery or transplant, patients may receive physical therapy to restore strength, increase flexibility, and minimise fatigue. A personalised workout regimen might help you improve your overall fitness and stamina.
Mobility assistance: Patients with limited movement due to treatment side effects may benefit from exercises to enhance balance and coordination.
Psychosocial support: Therapy or joining a support group can help cancer patients deal with the emotional and mental challenges of their treatment.
MediGence can assist and guide you in selecting the best physician and medical facility for your care.
Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.
Treatment regimens are adapted to the patient's specific cancer stage and location.
Instantly Connect with our Specialists
Hospitals for Hepatocellular Carcinoma (HCC) in India
Marengo Asia Hospitals, Gurugram
Gurgaon, India
- Marengo Asia Hospitals, Gurugram, is a 250-bed multi-speciality tertiary care hospital, formerly known as W Pratiksha Hospital.
- A major medical centre for Delhi NCR and North India, it is situated on Golf Course Extension Road, Sector 56, Gurugram.
- The hospital's NABH and NABL accreditation ensures compliance with international standards for patient care, safety, and quality.
- Provides extensive medical care in more than 21 specialities, including as women's health, neurology, orthopaedics, cardiology, and cancer.
- Advanced robotic-assisted spine surgery tools and neuro-monitoring technology are available at the Marengo Asia International Institute of Neuro & Spine (MAIINS), a Centre of Excellence in Neurosciences.
- Equipped with cutting-edge equipment, such as automated labs, sophisticated imaging, and contemporary operating rooms.
- Features specialised ICUs, NICUs, and modular OTs built for complex and minimally invasive procedures.
Jaslok Hospital & Research Center
Mumbai, India
- Jaslok Hospital & Research Centre, Mumbai, is a 350-bed super-speciality tertiary care hospital, established in 1973 and among India’s most respected private trust hospitals.
- Located on Peddar Road in South Mumbai, overlooking the Arabian Sea, it serves as a major referral centre for Mumbai, Maharashtra, and patients from across India and abroad.
- The hospital offers comprehensive care across 50+ specialities and nearly 20 multidisciplinary speciality clinics, addressing complex and advanced medical conditions.
- Supported by 300+ senior consultants and 200 resident doctors, ensuring high standards of expertise and round-the-clock patient care.
- Equipped with 75 ICU beds, advanced critical care units, modular operation theatres, and state-of-the-art diagnostic and imaging facilities.
- Recognised as a leading centre of excellence in Critical Care, Cardiac Sciences, Neurosciences, Oncosciences, Renal Sciences, Gastroenterology, and Assisted Reproduction.
- A prominent research and academic institution, conducting clinical trials and recognised by the National Board of Examinations (NBE) in 22 specialities.
- Strong emphasis on quality, patient safety, and evidence-based care, with continuous monitoring of clinical and operational outcomes to meet international healthcare standards.
Apollo Hospitals Bannerghatta
Bangalore, India
Apollo Hospitals Bannerghatta located in Bengaluru, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:
- Bed Capacity is 250
- Largest and most sophisticated sleep laboratory in the world
- Technological powerhouse with latest equipments
- 120 slice CT angiogram
- 3 Tesla MRI
- Low energy & High energy Linear Accelerators
- Navigation System in surgical procedures
- 4-D Ultrasound for 4 dimensional sonography
- Digital Fluoroscopy
- Gamma Camera
- Stereotactic Robotic Radio- surgery
- Autologous Bone Marrow Transplantation
- Robotic assisted surgeries
- Thallium Laser-First in India
- Holmium Laser-First in South India
- Digital X-Ray-First in Karnataka
- 100 plus consultants
- Uses Y shaped stent for tracheoesophageal fistula
- Four autologous chondrocyte implantations procedure is performed and several more like Spinal angiolipoma excision, Tibial tuberosity shift with MPSL reconstruction
- Biggest series of airway stents in India
- The Minimal Access Surgery Centre (MASC) centre of excellence
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Hepatocellular Carcinoma (HCC) Treatment?
Here are some of the reasons for choosing India:
- Due to advancements in medical facilities, such as minimally invasive surgical techniques.
- World-class experts include highly experienced doctors, JCI, and NABH-accredited healthcare institutions.
- Compared to other countries, treatment in Indian hospitals is cost-effective.
- Indian hospitals provide International patient services, including a multilingual support system.
- Improved treatment methods and biological therapies
Frequently Asked Questions
Yes, liver transplantation is a possibility for patients with early-stage HCC, mainly if the tumour is localised to the liver and the patient has cirrhosis. India has several transplant centres that provide this procedure.
Early diagnosis and treatment increase the chance of survival. Surgical resection or liver transplantation can provide a cure in the early stages, while modern therapies such as targeted medicines and immunotherapy can enhance quality of life and increase survival.
Survival rates vary depending on the stage of diagnosis. Early-stage HCC treated with surgery or liver transplantation has a much greater survival rate; however, advanced cases may have a poorer survival rate despite treatment. Early diagnosis and treatment significantly enhance outcomes.
Yes, lifestyle changes include:
- Consuming a nutritious diet rich in fruits and vegetables.
- Exercise regularly to maintain a healthy weight.
- Avoid alcohol and smoking.
- Managing chronic liver illnesses such as hepatitis or fatty liver can help avoid or better manage HCC.
HCC is one of the most common malignancies in India, particularly in areas with a high prevalence of hepatitis B and C infections. However, its prevalence is on the rise as non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver damage become more common.
Many patients can retain a high quality of life thanks to improved treatments such as surgery, liver transplants, and tailored medications. However, the disease's impact varies depending on the stage of cancer and the available treatment options.